[Management of Arterial Hypertension]

Overview

Journal Herz

Specialty Cardiology & Vascular Diseases

Date 2017 May 31

PMID 28555286

Citations 13

Authors

J A Wermelt

H Schunkert

Affiliations

Soon will be listed here.

Abstract

Arterial hypertension has a high prevalence and is a major risk factor for the development of cardiovascular diseases. It is a major contributor to worldwide morbidity and mortality and hence poses a huge socioeconomic burden. Despite great progress in perception, diagnosis and treatment of hypertension, blood pressure control is inadequate in less than half of the hypertensive patients (<140/90 mm Hg). The diagnosis of arterial hypertension starts in most patients with the conventional office blood pressure measurement. Out-of-office blood pressure measurement is an important adjunct, especially to unmask white-coat hypertension. To reach the right target blood pressure many effective antihypertensive drugs are available. By how much the blood pressure should be lowered is currently a matter of controversy. The 2013 European and the identical German national guidelines recommend a target blood pressure of <140/90 mm Hg for most patients. The recent SPRINT study revealed that some patients may benefit from an even lower blood pressure. This CME-article summarizes recent developments in the management of arterial hypertension and provides tips for daily practice based on these aims.

Citing Articles

Risk factors for cardiovascular and cerebrovascular events in patients with uremia and hypertension during maintenance hemodialysis.

Zhang X, Zhang W, Wang F, Chu Y Am J Transl Res. 2024; 16(4):1228-1236.

PMID: 38715830 PMC: 11070352. DOI: 10.62347/UAZN4638.

Beneficial Effects of Supplementation in the Management of Cardiovascular Diseases.

Prete V, Abate A, Di Pietro P, De Lucia M, Vecchione C, Carrizzo A Nutrients. 2024; 16(5).

PMID: 38474769 PMC: 10935118. DOI: 10.3390/nu16050642.

MicroRNAs: The Missing Link between Hypertension and Periodontitis?.

Rodriguez N, Loren P, Paez I, Martinez C, Chaparro A, Salazar L Int J Mol Sci. 2024; 25(4).

PMID: 38396672 PMC: 10889313. DOI: 10.3390/ijms25041992.

The Association between Magnesium Depletion Score and Hypertension in US Adults: Evidence from the National Health and Nutrition Examination Survey (2007-2018).

Tan M, Mo C, Zhao Q Biol Trace Elem Res. 2023; 202(10):4418-4430.

PMID: 38147232 DOI: 10.1007/s12011-023-04034-y.

A survey of data element perspective: Application of artificial intelligence in health big data.

Xiong H, Chen H, Xu L, Liu H, Fan L, Tang Q Front Neurosci. 2022; 16:1031732.

PMID: 36389224 PMC: 9641178. DOI: 10.3389/fnins.2022.1031732.

References

Jordan J . [Pathophysiology of hypertension : What are our current concepts?]. Internist (Berl). 2015; 56(3):219-23. DOI: 10.1007/s00108-014-3572-0. View

Chobanian A . Hypertension in 2017-What Is the Right Target?. JAMA. 2017; 317(6):579-580. DOI: 10.1001/jama.2017.0105. View

Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

Bliziotis I, Destounis A, Stergiou G . Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012; 30(7):1289-99. DOI: 10.1097/HJH.0b013e3283531eaf. View

Steffen H . [Epidemiology of hypertension: Prevalence, Awareness and Treatment]. MMW Fortschr Med. 2016; 158(17):63-70. DOI: 10.1007/s15006-016-8781-0. View

Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

Weber M, Poulter N, Schutte A, Burrell L, Horiuchi M, Prabhakaran D . Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global Perspective. Hypertension. 2016; 68(2):266-8. DOI: 10.1161/HYPERTENSIONAHA.116.07818. View

Williams B, MacDonald T, Morant S, Webb D, Sever P, McInnes G . Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015; 386(10008):2059-2068. PMC: 4655321. DOI: 10.1016/S0140-6736(15)00257-3. View

Ward A, Takahashi O, Stevens R, Heneghan C . Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. 2012; 30(3):449-56. DOI: 10.1097/HJH.0b013e32834e4aed. View

10.

Weber M, Bloch M, Bakris G, Weir M, Zappe D, Dahlof B . Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016; 18(4):299-307. PMC: 8032014. DOI: 10.1111/jch.12816. View

11.

Lonn E, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P . Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016; 374(21):2009-20. DOI: 10.1056/NEJMoa1600175. View

12.

Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah A, Denaxas S . Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014; 383(9932):1899-911. PMC: 4042017. DOI: 10.1016/S0140-6736(14)60685-1. View

13.

Zidek W . [Hypertension update 2016]. MMW Fortschr Med. 2016; 158(20):52-59. DOI: 10.1007/s15006-016-8236-7. View

14.

Kjeldsen S, Lund-Johansen P, Nilsson P, Mancia G . Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials. Hypertension. 2016; 67(5):808-12. DOI: 10.1161/HYPERTENSIONAHA.116.07257. View

15.

. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014; 384(9943):591-598. DOI: 10.1016/S0140-6736(14)61212-5. View

16.

Middeke M . [Antihypertensive drug therapy : Where do we stand?]. Internist (Berl). 2015; 56(3):230-9. DOI: 10.1007/s00108-014-3570-2. View

17.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-13. DOI: 10.1016/s0140-6736(02)11911-8. View

18.

Schunkert H . Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease. J Mol Med (Berl). 1998; 75(11-12):867-75. DOI: 10.1007/s001090050178. View

19.

Vasan R, Beiser A, Seshadri S, Larson M, Kannel W, DAgostino R . Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002; 287(8):1003-10. DOI: 10.1001/jama.287.8.1003. View

20.

Groha P, Schunkert H . [Management of arterial hypertension]. Herz. 2015; 40(6):929-40. DOI: 10.1007/s00059-015-4349-5. View